Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWynnstay Regulatory News (WYN)

Share Price Information for Wynnstay (WYN)

Share Price is delayed by 15 minutes
Get Live Data
345.00    0.00 (0.00%)
Bid:
340.00
Ask:
350.00
Spread: 10.00 (2.941%)
Market Cap: £79.42m
WYN Live PriceLast checked at - London Stock Exchange

Intraday Wynnstay Share Chart

Trading Update

1 Dec 2025 07:00

RNS Number : 6378J
Wynnstay Group PLC
01 December 2025
 

1 December 2025

 

Wynnstay Group plc

("Wynnstay" or "the Group" or "the Company")

Trading update for the year ended 31 October 2025

 

Project Genesis driving strong performance ahead of market expectations

 

Wynnstay Group plc, the agricultural supplies group, today issues its trading update for the year ended 31 October 2025.

 

The Board expects underlying trading results for the year to be modestly ahead of current market expectations1 with adjusted2 profit before tax of approximately £9.0m.

 

The performance reflects the early, tangible benefits of Project Genesis, which is sharpening commercial focus, improving pricing discipline, strengthening margins and driving operational efficiencies across the Group. Importantly, the behavioural changes implemented this year are embedding a more disciplined operating model and establishing a stronger platform for further growth in FY26 and beyond.

 

Feed & Grain

Feed & Grain delivered higher year-on-year profitability. Feed volumes were lower, reflecting lower poultry volumes as outlined in the interim results, but stronger margins and firm cost control supported improved results. Additional cost savings followed the planned closure of the Twyford mill. The Carmarthen expansion, adding 20,000 tonnes of capacity, is largely complete and positions Feed well for FY26. Grain trading was affected by a weaker wheat harvest and continued low wheat prices, which constrained volumes and margins. Operational discipline remained strong, and the integration of all trading activities into the unified GrainLink model was completed on schedule.

 

Arable

Arable profits increased year-on-year. Blended fertiliser sales under the Glasson Fertilisers brand were significantly higher, supported by the successful opening of the new Avonmouth blending facility. Pricing discipline and strategic purchasing decisions further strengthened margins. Seed sales benefited from a strong autumn grass season. Net margins across the segment improved, reflecting disciplined commercial execution and tight cost control.

 

StoresLike-for-like retail sales were broadly unchanged. Pricing control offset cost inflation, and operating costs were managed tightly, resulting in improved net margins.

 

Balance sheet

The Group generated good operating cash flow through the year and ended with net cash (pre IFRS 16 leases) of £26.4m (2024: £32.8m), providing investment capacity for the next phase of Project Genesis.

Non-recurring items

The design phase of Project Genesis is now complete, as is the Group-wide asset review we set out in our interim results. Integration activities have been implemented, including consolidation of trading operations under the GrainLink banner and completion of the integrations of Youngs Animal Feeds and Glasson Grain's specialist feed manufacturing. As a result of the asset review, manufacturing and warehousing operations at Glasson Dock (Lancaster) and Standon Mill (Staffordshire) have closed. These actions streamline the operating model and create a more efficient cost base.

 

As previously outlined in the interim results, these activities have given rise to associated non-recurring costs. These costs are expected to be in the range of £5.4m-£5.9m, subject to the audit, with a net cash cost of £2.0m-£2.5m after asset and working capital realisations. The final cost will be confirmed on completion of the remaining closure formalities. No further material restructuring charges are expected in FY26.

 

The HSE investigation that opened following a tragic fatality in January 2025 remains ongoing. As reported in the Group's interim results, we continue to assist all relevant authorities with their inquiries. We will provide a further update, as appropriate.

 

Outlook

Early trading in the new financial year is in line with the Board's expectations. The Group remains focused on disciplined execution of Project Genesis and delivery of targeted margin, cost and efficiency gains.

 

Audited results for the year ended 31 October 2025 will be released on Monday, 9 February 2026.

 

Alk Brand, Wynnstay CEO, commented: "The Group has delivered a strong performance for the year with tangible benefits of Project Genesis already materialising. This provides a strong platform for us to continue to invest in the business, supporting our long-term growth ambitions and we look forward to providing a further update on this at the time of our Full Year results."

 

1 Consensus for adjusted profit before tax of £8.5m (source: Factset)

 

2 Adjusted profit before taxation excludes amortisation of acquired intangibles, share-based payment expenses, gains or losses on mark to market of derivatives, non-recurring items and the share of tax incurred by joint ventures.

 

For more information on Wynnstay please visit https://www.wynnstayplc.co.uk/, or contact:

Wynnstay Group plc:

Alk Brand, Chief Executive Officer

Rob Thomas, Chief Financial Officer

 

 

Via Tavistock

Financial and Corporate communications:

Tavistock

Nick Dibden, Katie Hopkins, Grace Cooper

 

 

wynnstay@tavistock.co.uk

+44 (0) 207 920 3150

Nomad and Broker:

Shore Capital

Stephane Auton/Tom Knibbs (Corporate Advisory)

Henry Willcocks (Corporate Broking)

 

+44 (0) 20 7408 4090

About Wynnstay Group plc

 

Wynnstay Group plc supports livestock and arable farmers to produce food in a more sustainable, environmentally friendly and profitable way. They provide customers with high quality products, specialist advice and an efficient service that is industry leading.

The business is built on the foundation of offering customers the highest standard of customer service and specialist advice, to ensure they can achieve the best return on investment for their enterprise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKKBDKBDBDDN
Date   Source Headline
5th May 20262:31 pmRNSDirector and PDMR Shareholding
1st May 20267:00 amRNSAward of Options and Total Voting Rights
26th Mar 20263:31 pmRNSDirector/PDMR Shareholding
24th Mar 20265:11 pmRNSResult of AGM
24th Mar 20267:00 amRNSAGM Statement
2nd Mar 20267:00 amRNSBlock Listing Return
13th Feb 20263:30 pmRNSDirector/PDMR Shareholding
9th Feb 20264:40 pmRNSDividend timetable
9th Feb 20267:00 amRNSFinal Results
26th Jan 20267:00 amRNSNotice of Results and Investor presentation
29th Dec 202510:05 amRNSHolding(s) in Company
29th Dec 202510:05 amRNSHolding(s) in Company
1st Dec 202511:44 amRNSDirector/PDMR Share Purchases
1st Dec 20257:00 amRNSTrading Update
3rd Nov 20256:25 pmRNSDirector/PDMR Shareholding
6th Oct 20251:51 pmRNSDirector and PDMR dealing
24th Sep 20256:01 pmRNSDirector and PDMR dealing - Replacement
24th Sep 20253:50 pmRNSDirector and PDMR dealing
24th Sep 202512:05 pmRNSDirector and PDMR dealing
1st Sep 20257:00 amRNSBlock Listing Return
5th Aug 20255:10 pmRNSDirector Share Purchases
2nd Jul 20253:44 pmRNSPCA dealing
1st Jul 20252:20 pmRNSDirector Share Purchase
1st Jul 20257:00 amRNSInterim Results
16th Jun 20257:00 amRNSNotice of Results
2nd May 20257:00 amRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSDirector and PDMR dealing
30th Apr 202511:55 amRNSDirector/PDMR Shareholding
29th Apr 20254:22 pmRNSDirector and PDMR dealing
25th Apr 20253:04 pmRNSDirector/PDMR Shareholding
1st Apr 20259:26 amRNSDirector/PDMR Shareholding
27th Mar 20253:36 pmRNSResult of AGM
27th Mar 20257:00 amRNSAGM Update
25th Mar 20257:00 amRNSBoard Appointments
3rd Mar 202511:28 amRNSBlock Listing Return
27th Feb 20251:57 pmRNSChanges to Employee Share Scheme and TVR
20th Feb 20252:46 pmRNSDirector Dealing and Total Voting Rights
18th Feb 20254:32 pmRNSExercise of Options and Total Voting Rights
13th Feb 20255:31 pmRNSExercise of Options and Total Voting Rights
13th Feb 202512:54 pmRNSHolding(s) in Company - TR-1 Notification
12th Feb 20255:39 pmRNSExercise of Options, Director Dealings and TVR
11th Feb 20256:42 pmRNSDirector/PDMR dealings, Award of Options, TVR
11th Feb 20255:59 pmRNSCorrection of record date for final dividend
11th Feb 20257:00 amRNSFinal Results
21st Jan 20257:00 amRNSNotice of Final Results
31st Oct 20247:00 amRNSScrip dividend election, PDMR Dealing, TVR
30th Oct 20244:47 pmRNSDirector/PDMR Shareholdings
23rd Oct 20244:35 pmRNSDirector/PDMR Shareholding
18th Oct 20244:28 pmRNSTR-1 Notification
14th Oct 20244:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.